SITC Resource Library

Presentation slides and video from the 2021-2022 Advances in Cancer Immunotherapy^™ Series - A Focus on Intratumoral Therapies, Vaccines, and Cytokines held virtually on January 27, 2022 are available here.

Program Organizers

• Elizabeth Buchbinder, MD – Dana-Farber Cancer Institute
• Ryan J. Sullivan, MD – Massachusetts General Hospital
• Virginia Seery, MSN, RN, ANP, AOCNP – Beth Israel Deaconess Medical Center

Program Summary

Specifically designed by the Society for Immunotherapy of Cancer (SITC) for clinical oncologists, registered nurses, nurse practitioners, pharmacists, emergency physicians and the entire cancer care team, the Advances in Cancer Immunotherapy™ (ACI) programs are half-day innovative programs will have the opportunity for in-depth training in immunotherapy treatment for a variety of topics from leaders in this specific field. The ACI program also featured a discussion of closed cases submitted from attendees to hear guidance and insights from expert faculty. 

Program Learning Objectives 

• Describe the mechanisms of intratumoral therapies, vaccines and cytokines.
• Summarize recent updates in the use of intratumoral therapies, vaccines and cytokines clinically and toxicity management for key disease states.
• Outline common toxicities with intratumoral therapies, vaccines and cytokines and their management.

Please note on-demand recordings are not available for continuing education credits.

#AdvancesinCancerImmunotherapy(ACI)#2022#Vaccines#Cytokines#PresentationSlides#Video